Dr Natasha Monin is an accomplished Medical Executive with over 26 years experience in Biopharma and healthcare industries across AUS/NZ and Asia Pacific Region (Japan, China, S Korea, India, Taiwan/HK) with the last 10 years as Regional APAC Medical Director. A physician, Dr Monin is currently employed with UCB BioPharma as a Global Medical Learning Partner in Neurology. She serves on Snoretox board in a private capacity.
With specific interest in clinical development, product life-cycle strategies, business development, medical affairs and physicians medical learning, Natasha combines extensive international experience in strategic and operational leadership roles across Australia and Asia Pacific region.
Dr Monin has built a strong scientific expertise in a rich portfolio across a range of biologic and chemical entities in neurology, immunology (RA, SpA, Lupus), oncology, cardiovascular, women health, and anaesthesia. She acts as a Scientific Advisory Committee Member and clinical grants reviewer at the Cure Brain Cancer Foundation (AUS)